DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, today announced $10.05 million in research grants that aim to improve patient lives through better treatments for metastatic disease and advancements in precision medicine. The 32 grants will further cutting-edge breast cancer research being done at 27 prestigious institutions worldwide and continue Komen’s longstanding support of breast cancer researchers early in their careers, as well as the world’s leaders in the field..

达拉斯--（商业新闻短讯）--世界领先的乳腺癌组织Susan G.Komen®今天宣布了1050万美元的研究资助，旨在通过更好的转移性疾病治疗和精准医学的进步来改善患者的生活。这32笔赠款将进一步推动全球27家知名机构正在进行的前沿乳腺癌研究，并继续支持Komen在乳腺癌研究人员职业生涯早期以及该领域的世界领导者的长期支持。。

“Susan G. Komen’s work is not complete until we can save all lives from breast cancer, and the research we’re funding today is helping people with breast cancer to live longer with better outcomes,” said Paula Schneider, president and CEO of Komen, and a breast cancer survivor. “Komen’s grants will give promising scientists who are in pivotal stages of their careers the support they need to become the next generation of breast cancer leaders and advance research to save more lives.”.

Komen总裁兼首席执行官、乳腺癌幸存者PaulaSchneider说：“在我们能够挽救所有乳腺癌患者的生命之前，苏珊·科门的工作还没有完成，我们今天资助的研究正在帮助乳腺癌患者延长寿命，取得更好的结果。”。“科门的资助将为处于职业生涯关键阶段的有前途的科学家提供必要的支持，使他们成为下一代乳腺癌领导人，并推动研究以挽救更多生命。”。

Komen is providing its first Career Transition Award grants this year to support and maintain talented breast cancer researchers by helping senior postdoctoral fellows and clinical fellows working under mentors to launch competitive, independent breast cancer research careers. Komen is also continuing the ASPIRE grant, which was introduced last year, to support research trainees from historically marginalized communities in research to help build a breast cancer research workforce that reflects the diverse communities Komen serves..

Komen今年提供了其第一笔职业过渡奖赠款，通过帮助资深博士后研究员和在导师指导下工作的临床研究员启动具有竞争力的独立乳腺癌研究职业，来支持和维持有才能的乳腺癌研究人员。Komen还在继续去年推出的ASPIRE grant，以支持来自历史边缘化社区的研究受训人员进行研究，帮助建立一支反映Komen服务的不同社区的乳腺癌研究队伍。。

“This critical investment underscores Komen’s commitment to supporting cutting-edge research and innovative science that will lead to new treatment options for breast cancer, including metastatic breast cancer and other aggressive forms of the disease, and advance personalized breast cancer care, all with the goal of helping people live longer, better lives,” said Ann Partridge, MD, MPH, Chief Scientific Advisor for Komen..

科门首席科学顾问、医学博士、公共卫生硕士安·帕特里奇（AnnPartridge）表示：“这项关键投资突显了科门对支持前沿研究和创新科学的承诺，这些研究和创新科学将为乳腺癌（包括转移性乳腺癌和其他侵袭性乳腺癌）带来新的治疗选择，并推进个性化乳腺癌护理，所有这些都旨在帮助人们活得更长、更好。”。。

Dr. Partridge is the Eric P. Winer, M.D., Chair in Breast Cancer Research, Vice Chair of the Department of Medical Oncology, Director of the Adult Survivorship Program and Director of the Program for Young Women with Breast Cancer at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School..

帕特里奇博士是医学博士埃里克·怀纳（EricP.Winer），乳腺癌研究主席，医学肿瘤学系副主任，达纳·法伯癌症研究所（DanaFarber Cancer Institute）成人生存计划主任和乳腺癌年轻女性计划主任，哈佛医学院（Harvard Medical School）医学教授。。

Key Highlights of the $10.05 Million Investment:

1050万美元投资的主要亮点：

71% Dedicated to Metastatic and Aggressive Breast Cancer Research, addressing the most advanced form of breast cancer that is responsible for more than 40,000 breast cancer deaths every year. Metastatic breast cancer has no cure, and these grants focus on understanding the underlying biology and developing new ways to detect and treat metastatic and aggressive breast cancers to extend and maintain quality of life..

71%致力于转移性和侵袭性乳腺癌研究，解决了每年导致40000多例乳腺癌死亡的最晚期乳腺癌。转移性乳腺癌无法治愈，这些赠款侧重于了解潜在的生物学，并开发检测和治疗转移性和侵袭性乳腺癌的新方法，以延长和维持生活质量。。

65% Focused on Precision Medicine, also known as personalized medicine, which aims to tailor treatments specifically to individual patients and their unique tumors. Precision medicine aims to give patients treatments they’re most likely to benefit from, avoiding unnecessary treatment and improving outcomes..

65%的人专注于精准医学，也称为个性化医学，旨在专门针对个别患者及其独特的肿瘤量身定制治疗方法。精准医学旨在为患者提供最有可能受益的治疗，避免不必要的治疗并改善预后。。

With this year’s grants, Komen has now invested nearly $1.1 billion in critical, cutting-edge breast cancer research, making it the largest nonprofit funder of breast cancer research outside of the U.S. government.

通过今年的拨款，科门现在已经在关键的尖端乳腺癌研究中投资了近11亿美元，使其成为美国政府以外最大的非营利乳腺癌研究资助者。

'Supporting outstanding researchers is not just an investment, it is a lifeline for the future,” said Jennifer A. Pietenpol, Ph.D., Chief Scientific Advisor at Komen. “Komen's unwavering commitment to funding the best and brightest breast cancer researchers, especially in the crucial early stages of their careers, will ensure we have an exceptional team for generations to come.'.

Komen首席科学顾问Jennifer a.Pietenpol博士说：“支持杰出的研究人员不仅仅是一项投资，也是未来的生命线。”。“科曼坚定不移地致力于资助最优秀和最聪明的乳腺癌研究人员，特别是在他们职业生涯的关键早期阶段，这将确保我们拥有一支优秀的团队，为子孙后代服务。”。

Pietenpol is the Chief Scientific and Strategy Officer and Executive Vice President for Research at Vanderbilt University Medical Center and Ingram Professor of Cancer Research and Professor of Biochemistry at the Vanderbilt School of Medicine.

Pietenpol是范德比尔特大学医学中心首席科学与战略官兼研究执行副总裁，范德比尔特医学院英格拉姆癌症研究教授和生物化学教授。

Recipients of ASPIRE Grants: A Supplement to Promote Inclusion for Research Excellence

ASPIRE赠款的获得者：促进卓越研究包容性的补充

Eran Andrechek (Principal Investigator), Jesus Garcia-Lerena (Trainee), Michigan State University

密歇根州立大学Jesus Garcia Lerena（实习生）Eran Andrechek（首席研究员）

Paula Bos (Principal Investigator), Ailen Garcia-Santillan (Trainee), Virginia Commonwealth University

弗吉尼亚联邦大学Ailen Garcia Santillan（实习生）Paula Bos（首席研究员）

Eida Castro (Principal Investigator), Lianel Rosario (Trainee), Ponce Medical School Foundation, Inc.

艾达·卡斯特罗（首席研究员），Lianel Rosario（实习生），庞塞医学院基金会。

Isaac Chan (Principal Investigator), Isabella Terrazas (Trainee), The University of Texas Southwestern Medical Center

德克萨斯大学西南医学中心Isaac Chan（首席研究员），Isabella Terrazas（实习生）

Suranganie Dharmawardhane (Principal Investigator), Ailed Cruz-Collazo (Trainee), University of Puerto Rico, Medical Sciences Campus

Suranganie Dharmawardhane（首席研究员），Ailed Cruz Collazo（实习生），波多黎各大学医学院

Stephanie Fraley (Principal Investigator), Maya Rowell, (Trainee), University of California, San Diego

斯蒂芬妮·弗雷利（首席研究员），玛雅·罗威尔（实习生），加利福尼亚大学圣地亚哥分校

Aimilia Gastounioti (Principal Investigator), Juanita Hernandez (Trainee), Washington University in St. Louis

Aimilia Gastounioti（首席研究员），Juanita Hernandez（实习生），圣路易斯华盛顿大学

Christy Hagan (Principal Investigator), Julio Tinoco (Trainee), University of Kansas Medical Center Research Institute, Inc.

Christy Hagan（首席研究员），Julio Tinoco（实习生），堪萨斯大学医学中心研究所。

Kevin Janes (Principal Investigator), Catalina Alvarez Yela (Trainee), University of Virginia

弗吉尼亚大学卡塔琳娜·阿尔瓦雷斯·耶拉（实习生）凯文·詹斯（首席研究员）

Anne Marie McCarthy (Principal Investigator), Mattia Mah’Moud (Trainee), University of Pennsylvania

安妮·玛丽·麦卡锡（首席研究员），马蒂亚·马哈茂德（实习生），宾夕法尼亚大学

Heather Neuman (Principal Investigator), Faith Dickerson (Trainee), University of Wisconsin-Madison

Heather Neuman（首席研究员），Faith Dickerson（实习生），威斯康星大学麦迪逊分校

Julie Palmer (Principal Investigator), Etienne Holder (Trainee), Boston University

Julie Palmer（首席研究员），Etienne Holder（实习生），波士顿大学

Weston Porter (Principal Investigator), Hannah Carter (Trainee), Texas A&M AgriLife Research

Weston Porter（首席研究员）、Hannah Carter（实习生）、Texas A＆M AgriLife Research

Jeffrey Rosen (Principal Investigator), Alex Smith (Trainee), Baylor College of Medicine

杰弗里·罗森（首席研究员），亚历克斯·史密斯（实习生），贝勒医学院

Sohail Tavazoie (Principal Investigator), King Faisal Yambire (Trainee), The Rockefeller University

Sohail Tavazoie（首席研究员），费萨尔·亚姆比尔国王（实习生），洛克菲勒大学

Hai Wang (Principal Investigator), Cheyenne Ernst (Trainee), Roswell Park Alliance Foundation

Alana Welm (Principal Investigator), Zannel Blanchard (Trainee), The University of Utah

犹他大学的Alana Welm（首席研究员），Zannel Blanchard（实习生）

Recipients of Career Transition Awards

职业过渡奖获得者

Moriah Bellissimo, Virginia Commonwealth University

弗吉尼亚联邦大学莫里亚·贝利西莫

Kristen Brantley, Dana-Farber Cancer Institute

克里斯汀·布兰特利，达纳·法伯癌症研究所

Douglas B. Fox, Massachusetts General Hospital

道格拉斯·B·福克斯，马萨诸塞州总医院

Siting Gan, Memorial Sloan Kettering Cancer Center

斯廷甘纪念斯隆·凯特琳癌症中心

Emanuela Marchese, Massachusetts General Hospital

马萨诸塞州总医院Emanuela Marchese

Long Chi Nguyen, The University of Chicago

Long Chi Nguyen，芝加哥大学

Purab Pal, University of Illinois at Chicago

Purab Pal，伊利诺伊大学芝加哥分校

Nolan Priedigkeit, Dana-Farber Cancer Institute

Nolan Pride，Dana Farber癌症研究所

Yifan Wang, University of Texas M.D. Anderson Cancer Center

王一凡，德克萨斯大学安德森医学博士癌症中心

Jun Nishida, Dana-Farber Cancer Institute

Recipients of Big Data For Breast Cancer Grants

乳腺癌赠款大数据接受者

Xin Lu, University of Notre Dame

新露，圣母大学

Harikrishna Nakshatri, Indiana University

印第安纳大学Harikrishna Nakshatri

Recipients of Leadership Grants

领导才能补助金获得者

Lisa Coussens, Oregon Health & Science University

Lisa Coussens，俄勒冈州健康与科学大学

Christina Curtis, Stanford University

斯坦福大学克里斯蒂娜·柯蒂斯

Melissa Troester, The University of North Carolina at Chapel Hill

梅丽莎·特罗斯特（MelissaTroester），北卡罗来纳大学教堂山分校

Visit Komen’s website to learn more about this year’s research grants and recipients.

访问Komen的网站，了解更多有关今年研究资助和接受者的信息。

About Susan G. Komen®

关于Susan G.Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide.

Susan G.Komen®是世界领先的非营利乳腺癌组织，致力于挽救生命和永远终止乳腺癌。Komen拥有无与伦比的全面360度方法，可以在各个方面抗击这种疾病，并为美国和世界各国的数百万人提供支持。

We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures.

我们倡导患者，推动研究突破，改善获得高质量护理的机会，提供直接的患者支持，并为人们提供可靠的信息。由南希·G·布林克（NancyG.Brinker）创立，她向姐姐苏珊·G·科门（SusanG.Komen）承诺，她将结束夺走苏西生命的疾病，科门（Komen）仍然致力于支持今天受乳腺癌影响的人，同时不知疲倦地寻找明天的治疗方法。

Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/..

访问komen.org或致电1-877 GO komen。通过社交网站www.komen.org/contact-us/follow-us/与我们联系。。